Gregory Weaver
Director/Board Member chez Harborpath, Inc.
Fortune : 101 $ au 31/03/2024
Profil
Gregory L.
Weaver is currently the Director at BioIntelliSense, Inc. and the Director at Harborpath, Inc. Previously, he held positions such as Director at SCOLR Pharma, Inc., Chief Financial Officer, Director & Executive VP at Atossa Therapeutics, Inc., Independent Director at Zyla Life Sciences LLC, Chief Financial Officer, Secretary & VP at MDRNA, Inc., Chief Financial Officer at Poniard Pharmaceuticals, Inc., Chief Financial Officer & Senior Vice President at Sirna Therapeutics, Inc., CFO, Secretary, Treasurer & Senior Vice President at Fibrocell Science, Inc., Chief Financial Officer & Senior Vice President at Imunon, Inc., Chief Financial Officer at ILEX Oncology, Inc., Chief Financial Officer at Sevion Therapeutics, Inc., Chief Financial Officer at Liminal BioSciences, Inc., Global Chief Financial Officer & Executive VP at Oryzon Genomics SA, Chief Financial Officer at Prism Technologies, Inc., Chief Financial Officer at Verity Solutions Group, Inc., Chief Financial Officer at Oncology, Inc., Member-Supervisory Board at TME Pharma NV, Chief Financial & Accounting Officer at Eloxx Pharmaceuticals, Inc., and Chief Financial Officer at ATAI Life Sciences NV.
He obtained an undergraduate degree from Trinity University and an MBA from Boston College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/03/2024 | 56 ( 0,00% ) | 101 $ | 31/03/2024 |
Postes actifs de Gregory Weaver
| Sociétés | Poste | Début |
|---|---|---|
| Harborpath, Inc. | Director/Board Member | - |
BioIntelliSense, Inc.
 BioIntelliSense, Inc. Packaged SoftwareTechnology Services BioIntelliSense, Inc. engages in developing a medical grade data services platform for continuous health monitoring, predictive analytics and algorithmic clinical insights. The company was founded by James Ritchie Mault in 2018 and is headquartered in Redwood City, CA. | Director/Board Member | 01/06/2023 |
Anciens postes connus de Gregory Weaver
| Sociétés | Poste | Fin |
|---|---|---|
| ATOSSA THERAPEUTICS, INC. | Director of Finance/CFO | 05/10/2023 |
| TME PHARMA N.V. | Director/Board Member | 30/09/2022 |
| ATAI LIFE SCIENCES N.V. | Director of Finance/CFO | 16/08/2022 |
| ELOXX PHARMACEUTICALS, INC. | Director of Finance/CFO | 15/03/2020 |
| ZYLA LIFE SCIENCES | Director/Board Member | 01/01/2020 |
Formation de Gregory Weaver
| Trinity University | Undergraduate Degree |
| Boston College | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 8 |
|---|---|
| PONIARD PHARMACEUTICALS, INC. | Health Technology |
| IMUNON, INC. | Health Technology |
| LIMINAL BIOSCIENCES INC. | Health Technology |
| ATOSSA THERAPEUTICS, INC. | Health Technology |
| ORYZON GENOMICS S.A. | Health Technology |
| TME PHARMA N.V. | Health Technology |
| ELOXX PHARMACEUTICALS, INC. | Health Technology |
| ATAI LIFE SCIENCES N.V. | Health Technology |
| Entreprise privées | 12 |
|---|---|
MDRNA, Inc.
 MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | Commercial Services |
Sirna Therapeutics, Inc.
 Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | Commercial Services |
Fibrocell Science, Inc.
 Fibrocell Science, Inc. Pharmaceuticals: MajorHealth Technology Fibrocell Science, Inc. is an autologous cell and gene therapy company, which focuses on translating personalized biologics into medical breakthroughs for diseases affecting the skin and connective tissue. The company was founded on December 28, 1995 and is headquartered in Exton, PA. | Health Technology |
ILEX Oncology, Inc.
 ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | Health Technology |
SCOLR Pharma, Inc.
 SCOLR Pharma, Inc. Pharmaceuticals: MajorHealth Technology SCOLR Pharma, Inc. is a pharmaceutical company, engages in proprietary and patented Controlled Delivery Technology platforms to develop and commercialize novel prescription, over-the-counter and nutritional products. The company's technology is used to develop dietary supplement products, including combinations of glucosamine and chondroitin, niacin, calcium, and other dietary products. Its lead product candidate is a CDT-based extended release formulation of ibuprofen, an analgesic typically used for the treatment of pain, fever and inflammation. SCOLR Pharma was founded in 1983 and is headquartered in Bellevue, WA. | Health Technology |
Sevion Therapeutics, Inc.
 Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | Commercial Services |
Zyla Life Sciences LLC
 Zyla Life Sciences LLC Pharmaceuticals: MajorHealth Technology Zyla Life Sciences is a commercial-stage company, which focuses on developing, manufacturing and commercializing innovative treatments for pain. It is focused on bringing non-narcotic products and abuse-discouraging formulations of opioids to patients and healthcare providers. The company plans to continue to grow revenue of its seven commercial products, which includes Sprix nasal spray, Vivlodex, Zorvolex, Tivorbex, Indocin suppositories, Indocin oral suspension and oxaydo tablets, and explore business development opportunities. Zyla Life Sciences was founded in August 2013 and is headquartered in Wayne, PA. | Health Technology |
Prism Technologies, Inc.
 Prism Technologies, Inc. Packaged SoftwareTechnology Services Prism Technologies, Inc. provides ebusiness enterprise solutions. It is a subsidiary of Watch Hill Investment Partners, Inc. and is headquartered in North Providence, RI. | Technology Services |
Verity Solutions Group, Inc.
 Verity Solutions Group, Inc. Packaged SoftwareTechnology Services Verity Solutions Group, Inc. specializes in software and services developed for administration of the federal 340B drug pricing program. Its solutions include split billing, contract pharmacy, specialty contract pharmacy, audit & compliance services, compliance manager, purchase analytics and VHUB. The company was founded by James E. Torina in 2002 and is headquartered in Kirkland, WA. | Technology Services |
Oncology, Inc.
 Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Dentsu Group, Inc., Oncology, Inc. provides oncology treatment information. The private company is based in Cherry Hill, NJ. Oncology was acquired by Aegis Group Plc on January 07, 2008. | Commercial Services |
BioIntelliSense, Inc.
BioIntelliSense, Inc. Packaged SoftwareTechnology Services BioIntelliSense, Inc. engages in developing a medical grade data services platform for continuous health monitoring, predictive analytics and algorithmic clinical insights. The company was founded by James Ritchie Mault in 2018 and is headquartered in Redwood City, CA. | Technology Services |
| Harborpath, Inc. |
